Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch

NCT04892654 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: Doravirine
DRUG: Dolutegravir
OTHER: Triple cART regimen

Sponsor

Chelsea and Westminster NHS Foundation Trust